A. Grein
Impact in
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Microbiology top 10%
Papers in
- Pharmacology 17
- Microbial Natural Products and Biosynthesis 17
-
- Chemical Synthesis and Analysis 3
- Phytochemical compounds biological activities 2
- Enzyme function and inhibition 2
- Co-authors
- C. Spalla (15 shared papers)Giuseppe Cassinelli (8 shared papers)Federico Arcamone (6 shared papers)P. Orezzi (3 shared papers)Samuel P. Meyers (1 shared paper)Anna Maria Casazza (3 shared papers)A Sanfilippo (1 shared paper)Aurelio Di Marco (2 shared papers)
- Journals
- The Journal of Antibiotics (5 papers)Archives of Microbiology (4 papers)Biotechnology and Bioengineering (2 papers)Cellular and Molecular Life Sciences (2 papers)Journal of Natural Products (1 paper)
- Partner nations
- ItalyGermanySwitzerland
In The Last Decade
A. Grein
22 papers receiving 871 citations
A. Grein's Hit Papers
Peers
Comparison fields: 5 of 97
- Pharmacology 347
- Microbiology 14
- Toxicology 48
- Biotechnology 118
- Oncology 227
Countries citing papers authored by A. Grein
This map shows the geographic impact of A. Grein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Grein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Grein more than expected).
Fields of papers citing papers by A. Grein
This network shows the impact of papers produced by A. Grein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Grein. The network helps show where A. Grein may publish in the future.
Co-authors
The 23 scholars most cited alongside A. Grein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius Hit paper breakdown → | 1969 | 531 |
| 2 | 1958 | 67 | |
| 3 | 2000 | 56 | |
| 4 | 1954 | 38 | |
| 5 | 1967 | 38 | |
| 6 | 1982 | 37 | |
| 7 | 1987 | 36 | |
| 8 | 1978 | 31 | |
| 9 | 1969 | 27 | |
| 10 | 1989 | 20 | |
| 11 | 1970 | 16 | |
| 12 | 1985 | 15 | |
| 13 | 1978 | 13 | |
| 14 | 1982 | 12 | |
| 15 | 1981 | 12 | |
| 16 | 1974 | 11 | |
| 17 | 1980 | 11 | |
| 18 | 1990 | 6 | |
| 19 | 1955 | 5 | |
| 20 | 1987 | 5 |
About A. Grein
A. Grein is a scholar working on Pharmacology, Molecular Biology, Organic Chemistry, Plant Science and Small Animals, having authored 24 papers that have together received 998 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (17 papers), Cancer Treatment and Pharmacology (3 papers), Chemical Synthesis and Analysis (3 papers), Synthesis and Biological Activity (3 papers), Infectious Diseases and Mycology (3 papers), Plant Disease Resistance and Genetics (2 papers), Phytochemical compounds biological activities (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Pharmacology (347 citations), Microbiology (14 citations), Toxicology (48 citations), Biotechnology (118 citations) and Oncology (227 citations). A. Grein has collaborated with scholars based in Italy, Germany and Switzerland. Frequent co-authors include C. Spalla, Giuseppe Cassinelli, Federico Arcamone, P. Orezzi, Samuel P. Meyers, Anna Maria Casazza, A Sanfilippo, Aurelio Di Marco, Graziella Pratesi and Nicoletta Crespi-Perellino. Their work appears in journals such as The Journal of Antibiotics, Archives of Microbiology, Biotechnology and Bioengineering, Cellular and Molecular Life Sciences and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.